444 related articles for article (PubMed ID: 37257328)
1. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
[TBL] [Abstract][Full Text] [Related]
3. Gualou xiebai decoction ameliorates cardiorenal syndrome type II by regulation of PI3K/AKT/NF-κB signalling pathway.
Wang YY; Liu YY; Li J; Zhang YY; Ding YF; Peng YR
Phytomedicine; 2024 Jan; 123():155172. PubMed ID: 37976694
[TBL] [Abstract][Full Text] [Related]
4. Forsythiaside A suppresses renal fibrosis and partial epithelial-mesenchymal transition by targeting THBS1 through the PI3K/AKT signaling pathway.
Tuoheti K; Bai X; Yang L; Wang X; Cao Y; Yisha Z; Guo L; Zhan S; Wu Z; Liu T
Int Immunopharmacol; 2024 Mar; 129():111650. PubMed ID: 38342062
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
6. Hovenianin A Alleviates Hepatic Fibrosis by Inhibiting the PI3K/AKT Pathway in TGF-β1-Induced HSCs Based on Network Pharmacology and Transcriptomic Analysis.
Kuang X; Ma T; Cai W; Yang J; Sun B; Zhang X; Liu B; Wang S; Xu F
Chem Biodivers; 2023 Mar; 20(3):e202201110. PubMed ID: 36825591
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis.
Dai H; Shan Y; Yu M; Wang F; Zhou Z; Sun J; Sheng L; Huang L; Sheng M
J Ethnopharmacol; 2024 Jan; 318(Pt A):116874. PubMed ID: 37437794
[TBL] [Abstract][Full Text] [Related]
9. Gypenosides suppress fibrosis of the renal NRK-49F cells by targeting miR-378a-5p through the PI3K/AKT signaling pathway.
Zhang L; Wang X; He S; Zhang F; Li Y
J Ethnopharmacol; 2023 Jul; 311():116466. PubMed ID: 37031821
[TBL] [Abstract][Full Text] [Related]
10. Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology-Molecular docking-Key target validation".
Zhou L; Wang X; Sun Z; Bao X; Xue L; Xu Z; Dong P; Xia J
PLoS One; 2023; 18(10):e0291621. PubMed ID: 37796994
[TBL] [Abstract][Full Text] [Related]
11. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
[TBL] [Abstract][Full Text] [Related]
12. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway.
Shi H; Deng L; Zhou Y; Yu H; Huang X; Chen M; Lei Y; Dong J
J Ethnopharmacol; 2023 Oct; 315():116691. PubMed ID: 37247682
[TBL] [Abstract][Full Text] [Related]
14. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
15. Rehmannia glutinosa Libosch and Cornus officinalis Sieb herb couple ameliorates renal interstitial fibrosis in CKD rats by inhibiting the TGF-β1/MAPK signaling pathway.
Zhu JH; Wang L; Ma ZX; Duan JA; Tao JH
J Ethnopharmacol; 2024 Jan; 318(Pt B):117039. PubMed ID: 37579922
[TBL] [Abstract][Full Text] [Related]
16. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
Wang YC; Hui JR; Xiao G; Ma QL
Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
19. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
[TBL] [Abstract][Full Text] [Related]
20. Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology.
Shao D; Liu X; Wu J; Zhang A; Bai Y; Zhao P; Li J
Phytomedicine; 2022 Jul; 102():154177. PubMed ID: 35636171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]